This inventor holds 6 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Lentigen Technology, Inc.. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: The Innovative Contributions of Waleed M. Haso in Cancer Treatment
Introduction
Waleed M. Haso, a prominent inventor based in Fair Lawn, New Jersey, has made significant strides in the field of medical biotechnology. With a focus on innovative cancer therapies, he holds five patents that contribute to advancing treatment methodologies and improving patient outcomes. His extensive work highlights the potential of immunotherapy in the fight against cancer.
Latest Patents
One of Haso's latest patents is focused on "Compositions and methods for treating cancer with DuoCARs." This patent details novel therapeutic immunotherapy compositions comprising at least two vectors, where each vector encodes a functional chimeric antigen receptor (CAR). The unique combination of vectors enables the expression of two or more non-identical binding domains. These binding domains are covalently linked to a transmembrane domain, enhancing the efficacy of the treatment. The innovation also entails providing one or more non-identical intracellular signaling motifs, presenting methods for patient-specific immunotherapy applicable for various cancers and other diseases.
Career Highlights
Currently, Waleed M. Haso is affiliated with Lentigen Technology, Inc., where he continues to pursue groundbreaking research and development in immunotherapy. His work has positioned him as a leader in the field, enabling advancements that support the treatment of complex diseases through innovative approaches.
Collaborations
Throughout his career, Haso has collaborated with esteemed coworkers such as Rimas J. Orentas and Dina Schneider. These alliances not only amplify the impact of their collective research efforts but also foster a collaborative environment that promotes groundbreaking discoveries in cancer treatment.
Conclusion
Waleed M. Haso exemplifies the spirit of innovation within the medical biotechnology sector. His contributions, particularly in the realm of cancer therapies, reflect the potential of scientific advancements to transform patient care. With a commitment to research and collaboration, he continues to be a significant figure in the development of effective treatment options for challenging diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile